Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Joseph

Showing results (531-540 of 547) with videos related to

Pageof 55
Sort By:
The Lancet. Microbe|March 3, 2024
Emergence of zoonotic sporotrichosis in Brazil: a genomic epidemiology studyAmanda Ribeiro Dos Santos, Elizabeth Misas, Brian Min, et al.
Nature Biotechnology|April 12, 2017
Toil enables reproducible, open source, big biomedical data analysesJohn Vivian, Arjun Arkal Rao, Frank Austin Nothaft, et al.
Nature Medicine|June 22, 2021
Integrated genomic, epidemiologic investigation of Candida auris skin colonization in a skilled nursing facilityDiana M Proctor, Thelma Dangana, D Joseph Sexton, et al.
Bioorganic & Medicinal Chemistry Letters|February 8, 2011
Discovery of INCB10820/PF-4178903, a potent, selective, and orally bioavailable dual CCR2 and CCR5 antagonistChangsheng Zheng, Ganfeng Cao, Michael Xia, et al.
Human Mutation|October 16, 2009
Identification of a DMBT1 polymorphism associated with increased breast cancer risk and decreased promoter activitySandrine Tchatchou, Angela Riedel, Stefan Lyer, et al.
Bioorganic & Medicinal Chemistry Letters|July 28, 2009
Optimization of the aminopyridopyrazinones class of PDE5 inhibitors: discovery of 3-[(trans-4-hydroxycyclohexyl)amino]-7-(6-methoxypyridin-3-yl)-1-(2-propoxyethyl)pyrido[3,4-b]pyrazin-2(1H)-oneRobert O Hughes, John K Walker, D Joseph Rogier, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Discovery of INCB8761/PF-4136309, a Potent, Selective, and Orally Bioavailable CCR2 AntagonistChu-Biao Xue, Anlai Wang, Qi Han, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 7, 2023
Rapid Environmental Contamination With Candida auris and Multidrug-Resistant Bacterial Pathogens Near Colonized PatientsSarah E Sansom, Gabrielle M Gussin, Michael Schoeny, et al.
The Journal of Physical Chemistry. B|June 4, 2014
All-atom empirical potential for molecular modeling and dynamics studies of proteinsA D MacKerell, D Bashford, M Bellott, et al.
Bioorganic & Medicinal Chemistry Letters|June 23, 2009
Investigation of aminopyridiopyrazinones as PDE5 inhibitors: Evaluation of modifications to the central ring systemRobert O Hughes, John K Walker, Jerry W Cubbage, et al.
Pageof 55

Showing results (531-540 of 547) with videos related to

Sort By:
Pageof 55
The Lancet. Microbe|March 3, 2024
Emergence of zoonotic sporotrichosis in Brazil: a genomic epidemiology studyAmanda Ribeiro Dos Santos, Elizabeth Misas, Brian Min, et al.
Nature Biotechnology|April 12, 2017
Toil enables reproducible, open source, big biomedical data analysesJohn Vivian, Arjun Arkal Rao, Frank Austin Nothaft, et al.
Nature Medicine|June 22, 2021
Integrated genomic, epidemiologic investigation of Candida auris skin colonization in a skilled nursing facilityDiana M Proctor, Thelma Dangana, D Joseph Sexton, et al.
Bioorganic & Medicinal Chemistry Letters|February 8, 2011
Discovery of INCB10820/PF-4178903, a potent, selective, and orally bioavailable dual CCR2 and CCR5 antagonistChangsheng Zheng, Ganfeng Cao, Michael Xia, et al.
Human Mutation|October 16, 2009
Identification of a DMBT1 polymorphism associated with increased breast cancer risk and decreased promoter activitySandrine Tchatchou, Angela Riedel, Stefan Lyer, et al.
Bioorganic & Medicinal Chemistry Letters|July 28, 2009
Optimization of the aminopyridopyrazinones class of PDE5 inhibitors: discovery of 3-[(trans-4-hydroxycyclohexyl)amino]-7-(6-methoxypyridin-3-yl)-1-(2-propoxyethyl)pyrido[3,4-b]pyrazin-2(1H)-oneRobert O Hughes, John K Walker, D Joseph Rogier, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Discovery of INCB8761/PF-4136309, a Potent, Selective, and Orally Bioavailable CCR2 AntagonistChu-Biao Xue, Anlai Wang, Qi Han, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 7, 2023
Rapid Environmental Contamination With Candida auris and Multidrug-Resistant Bacterial Pathogens Near Colonized PatientsSarah E Sansom, Gabrielle M Gussin, Michael Schoeny, et al.
The Journal of Physical Chemistry. B|June 4, 2014
All-atom empirical potential for molecular modeling and dynamics studies of proteinsA D MacKerell, D Bashford, M Bellott, et al.
Bioorganic & Medicinal Chemistry Letters|June 23, 2009
Investigation of aminopyridiopyrazinones as PDE5 inhibitors: Evaluation of modifications to the central ring systemRobert O Hughes, John K Walker, Jerry W Cubbage, et al.
Pageof 55